Polandās Legionnaires’ disease cases highest in 7 years
At least 23 people have died in Poland from Legionnaires' disease as of September 11, with a total of 166 cases being reported.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
At least 23 people have died in Poland from Legionnaires' disease as of September 11, with a total of 166 cases being reported.
Nigeria has recorded an āunusualā rise in diphtheria with 5,898 cases being reported during the three months ended August.
Every year about three million deaths occur globally due to unsafe healthcare and an estimated one in every 10 patient experience harm in.
The Central Intelligence Agency offered bribes to six analysts to change their position on COVID-19ās origins from a lab leak theory in China.
HQ Team September 13, 2023: The US national public agency has recommended a COVID-19 vaccination policy where updated shots are given starting from.
HQ Team September 12, 2023: The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal.
HQ Team September 12, 2023: Nuvectis Pharma, Inc., a US biopharmaceutical firm, has started its experimental trial in humans to treat solid tumors..
HQ Team September 12, 2023: The US drug and medicine regulator, the FDA, approved COVID-19 vaccinesĀ made by Moderna Inc., Pfizer Inc., andĀ BioNTech.
HQ Team September 12, 20232: Methamphetamine trafficking is expanding rapidly from the EU to Eastern Africa, changing illicit drug markets traditionally focused on.
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.